Pages that link to "Q33804467"
Jump to navigation
Jump to search
The following pages link to Immunosuppressant-induced nephropathy: pathophysiology, incidence and management (Q33804467):
Displaying 28 items.
- Atrial natriuretic peptide reduces cyclosporin toxicity in renal cells: role of cGMP and heme oxygenase-1. (Q30320876) (← links)
- Renal function following hematological stem cell transplantation in childhood (Q33347778) (← links)
- A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT. (Q33551422) (← links)
- Reducing adverse effects of immunosuppressive agents in kidney transplant recipients (Q34547749) (← links)
- Review article: monitoring for drug side-effects in inflammatory bowel disease (Q34585315) (← links)
- Toxoplasma gondii retinochoroiditis after cardiac transplantation (Q35116784) (← links)
- Cyclosporine renal dysfunction (Q35711141) (← links)
- Cardiovascular complications of immunosuppressive agents in renal transplant recipients. (Q36040739) (← links)
- New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. (Q36788871) (← links)
- Renal Deletion of 12 kDa FK506-Binding Protein Attenuates Tacrolimus-Induced Hypertension. (Q36849244) (← links)
- Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation (Q36945333) (← links)
- Treatment strategies to minimize or prevent chronic allograft dysfunction in pediatric renal transplant recipients: an overview (Q37624684) (← links)
- Drug-induced nephrotoxicity and its biomarkers (Q38153051) (← links)
- Conversion to everolimus in liver transplant patients with renal dysfunction (Q38427008) (← links)
- Incidence and risk factors for early renal dysfunction after liver transplantation (Q39294134) (← links)
- THE PURVIEW OF PHYTOTHERAPY IN THE MANAGEMENT OF KIDNEY DISORDERS: A SYSTEMATIC REVIEW ON NIGERIA AND SOUTH AFRICA. (Q39294722) (← links)
- Everolimus treatment downregulates renocortical cyclooxygenase-2 expression in the rat kidney. (Q43261412) (← links)
- Immunosuppression impact on long-term cardiovascular complications after liver transplantation (Q44009088) (← links)
- Cyclosporine A protects against apoptosis in ischaemic/reperfused rat kidneys (Q44091837) (← links)
- Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients (Q44101368) (← links)
- Impact of cardiac transplantation on kidney function: a single- center experience (Q44491120) (← links)
- Rapamycin preserves renal function compared with cyclosporine A after ischemia/reperfusion injury (Q44612413) (← links)
- Kidney graft function in long-term cyclosporine and tacrolimus treatment: comparative study with nephrotoxicity markers. (Q45958491) (← links)
- The calcineurin inhibitor FK506 (tacrolimus) is associated with transient metabolic acidosis and altered expression of renal acid-base transport proteins. (Q46013979) (← links)
- Chronic cyclosporine nephrotoxicity: a pig model (Q46812670) (← links)
- Macrolide Antibiotics and Calcineurin Inhibitors: Avoiding a Far too Common Drug Interaction in Transplant Patients (Q59314597) (← links)
- Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab (Q77355108) (← links)
- The role of immunosuppressive drugs in aggravating renal ischemia and reperfusion injury (Q79959698) (← links)